Skip to main content

Table 2 Percentage of IC50 values

From: Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma

Cell

IC50 (μM)

AZ

MS-275

AZ + MS-275

NSC6539

53

2.8

23.5

NSC6562

56

3

35

SH-SY5Y

45

1.23

17.5

SK-N-SH

42

1

16.5

SK-N-BE(2)

49

1.48

19.2

  1. Table 2 shows percentage of NSC6539, NSC6562, SH-SY5Y, SK-N-SH and SK-N-BE(2) by AZ (0–160 μM), MS-275 (0–3 μM), and AZ + MS-275 (0–160 μM + 0.75 μM) treatments (48 h)
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us